Entrada Therapeutics
TRDA
#6262
Rank
โ‚น56.13 B
Marketcap
โ‚น1,500
Share price
1.79%
Change (1 day)
22.25%
Change (1 year)

Revenue for Entrada Therapeutics (TRDA)

Revenue in 2024 (TTM): โ‚น17.94 Billion

According to Entrada Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น18.35 Billion. In 2023 the company made a revenue of โ‚น10.74 Billion an increase over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Entrada Therapeutics from 2021 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น17.94 B67.09%
2023 โ‚น10.74 B
2022 N/A
2021 N/A